The fluoride concentration in whole saliva and the effect of variations in salivary flow rate were studied in 5 volunteers after use of a chewing gum (Fluomin®) containing 0.25 mg fluoride as sodium fluoride. Basal fluoride concentration during 2 consecutive days ranged between 0.3 and 1.1 μmol/l. The salivary fluoride clearance was studied after chewing one piece of the gum. The clearance of fluoride showed three phases in the decline of the curve. The effect of multiple dosing of the fluoride gum was studied for 7 days, one piece of gum was chewed every 2nd hour during the day and whole saliva was sampled frequently. The subjects with a stimulated salivary flow rate ranging between 0.9 and 2.5 ml/min had a mean steady-state level of fluoride in the saliva ranging from 0.7 to 1.6 μmol/l. This was in contrast to the subjects with low salivary flow rate ranging between 0.4 and 0.6 ml/min, where the fluoride concentration ranged from 4.7 to 19.2 μmol/l. In a separate study, the fluoride concentration in plasma in 4 subjects was studied for 24 h following repeated use of 0.5 mg fluoride as two pieces of the gum 10 times a day. The plasma levels found ranged from 1 to 3 μmol/l.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.